Can patients scooping clinical trial results influence pharma stock?

Posted on Posted in Change management, Communities, Social Media

In the age of the Internet and social media portals such as Facebook and Twitter, investors are turning more and more to non-conventional sources of information to gain an advantage on investing in the stock market. With a little detective work, the ordinary retail investor can level the playing field versus the professional analyst or […]

Patient associations acquire the taste for social media

Posted on Posted in Communities, Multichannel, Social Media

Roche demonstrates it’s implication in helping patients through sponsoring workshops for patient associations. This novel approach was facilitated by Andrew Spong (rock on Andrew!): Patient associations acquire the taste for social media. Outcome: nearly all patient associations prefer Facebook and Twitter as their platforms of choice. What I fund really interesting is that that they […]

The state of online pharma communities

Posted on Posted in Communities, Social Media

The numbers tell a dismal story for pharma industry. After gaining ground last year in adopting community best practices, this year’s report data reveals stagnation. In 2012, 23 of the 32 best practices had less than 50 percent adoption.   Thirteen of the best practices had less than 30 percent adoption—most notably, advocate programs, mobile […]

Feasibility of a Wiki as a Participatory Tool for Patients in Clinical Guideline Development

Posted on 1 CommentPosted in Change management, Communities, Medical, Social Media

Feasibility of a Wiki as a Participatory Tool for Patients in Clinical Guideline Development… What is really interesting in this “scientific journal” is that Pharma is not part of the discussion. This should trigger some discussion from our side – should we be at the table? From my point of view the drugs are part […]